Literature DB >> 8604174

The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention.

D J Hu1, T J Dondero, M A Rayfield, J R George, G Schochetman, H W Jaffe, C C Luo, M L Kalish, B G Weniger, C P Pau, C A Schable, J W Curran.   

Abstract

The discovery of highly divergent strains of human immunodeficiency virus (HIV) not reliably detected by a number of commonly used diagnostic tests has underscored the need for effective surveillance to track HIV variants and to direct research and prevention activities. Pathogens such as HIV that mutate extensively present significant challenges to effective monitoring of pathogens and to disease control. To date, relatively few systematic large-scale attempts have been made to characterize and sequence HIV isolates. For most of the world, including the United States, information on the distribution of HIV strains among different population groups is limited. We describe herein the implications resulting from the rapid evolution of HIV and the need for systematic surveillance integrated with laboratory science and applied research. General surveillance guidelines are provided to assist in identifying population groups for screening, in applying descriptive epidemiology and systematic sampling, and in developing and evaluating efficient laboratory testing algorithms. Timely reporting and dissemination of data is also an important element of surveillance efforts. Ultimately, the success of global surveillance network depends on collaboration and on coordination of clinical, laboratory, and epidemiologic efforts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604174

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  47 in total

1.  Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance.

Authors:  A C Vicente; S M Agwale; K Otsuki; O M Njouku; D Jelpe; J A Idoko; E Caride; R M Brindeiro; A Tanuri
Journal:  Virus Genes       Date:  2001-03       Impact factor: 2.332

2.  Preventing emerging infectious diseases as we enter the 21st century: CDC's strategy.

Authors:  S Binder; A M Levitt; J M Hughes
Journal:  Public Health Rep       Date:  1999 Mar-Apr       Impact factor: 2.792

3.  Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom.

Authors:  P A Cane; A de Ruiter; P Rice; M Wiselka; R Fox; D Pillay
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

4.  In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice.

Authors:  Fatih M Uckun; Sanjive Qazi; Sharon Pendergrass; Elizabeth Lisowski; Barbara Waurzyniak; Chun-Lin Chen; T K Venkatachalam
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.

Authors:  Fatih M Uckun; Sharon Pendergrass; T K Venkatachalam; Sanjive Qazi; Douglas Richman
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

6.  Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2.

Authors:  K Abravaya; C Esping; R Hoenle; J Gorzowski; R Perry; P Kroeger; J Robinson; R Flanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

7.  Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities.

Authors:  L Heyndrickx; W Janssens; L Zekeng; R Musonda; S Anagonou; G Van der Auwera; S Coppens; K Vereecken; K De Witte; R Van Rampelbergh; M Kahindo; L Morison; F E McCutchan; J K Carr; J Albert; M Essex; J Goudsmit; B Asjö; M Salminen; A Buvé; G van Der Groen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Human immunodeficiency virus reverse transcriptase and protease sequence database.

Authors:  R W Shafer; D R Jung; B J Betts; Y Xi; M J Gonzales
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

9.  Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host.

Authors:  Joshua T Herbeck; David C Nickle; Gerald H Learn; Geoffrey S Gottlieb; Marcel E Curlin; Laura Heath; James I Mullins
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

10.  A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1.

Authors:  F Gao; D L Robertson; C D Carruthers; S G Morrison; B Jian; Y Chen; F Barré-Sinoussi; M Girard; A Srinivasan; A G Abimiku; G M Shaw; P M Sharp; B H Hahn
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.